Clinical Trials Browser

OTHER × Liposarcoma × camrelizumab × Clear all

NCT06694324 2024-11-19

First-line Treatment of Advanced/unresectable DDLPS

Phase 2 Not yet recruiting

Liposarcoma, Sarcoma